# Safety And Efficacy Of Spirinolactone Plus Hydroflumethiazide In The Treatment Of Filipino Patients With Hypertension

> **NCT01260857** · — · WITHDRAWN · sponsor: **Pfizer**

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Aldazide

## Key facts

- **NCT ID:** NCT01260857
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-03
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01260857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01260857, "Safety And Efficacy Of Spirinolactone Plus Hydroflumethiazide In The Treatment Of Filipino Patients With Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01260857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*